Back to Authors

Matte, Geneviève

A5112907699 | I4210142730

Mayo Clinic

Centre Hospitalier de l’Université de Montréal

Citations 1

A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration | September 24, 2020 | Volume: 22 | Issue: 3-4 | Pages: 287-299

10.1080/21678421.2020.1822410 | PMID 32969758